ABSTRACT
BACKGROUND: Neonatal sepsis, often attributed to Group B Streptococcus (GBS) infection, poses a critical health risk to infants, demanding rapid and accurate diagnostic approaches. Existing diagnostic approaches are dependent on traditional culture methods, a process that requires substantial time and has the potential to delay crucial therapeutic assessments. METHODS: This study introduces an innovative Loop-Mediated Isothermal Amplification (LAMP) assay for the early on-site detection of GBS infection from neonatal sepsis blood samples. To develop a LAMP assay, the primers are designed for the selective targeting of a highly conserved segment within the cfb gene encoding the CAMP factor in Streptococcus agalactiae ensuring high specificity. RESULTS: Rigorous optimization of reaction conditions, including temperature and incubation time, enhances the efficiency of the LAMP assay, enabling rapid and reliable GBS detection within a short timeframe. The diagnostic efficacy of the LAMP assay was evaluated using spiked blood samples by eliminating the DNA extraction step. The simplified colorimetric LAMP assay has the capability to detect S. agalactiae in a neonatal blood sample containing 2 CFU/mL during sepsis. Additionally, the LAMP assay effectively detected S. agalactiae in both the standard and spiked blood samples, with no detectable interference with blood. CONCLUSION: This optimised LAMP assay emerges as a promising tool for early GBS detection, offering a rapid and accurate on-site solution that has the potential to inform timely interventions and improve outcomes in neonatal sepsis cases.
Subject(s)
Molecular Diagnostic Techniques , Neonatal Sepsis , Nucleic Acid Amplification Techniques , Streptococcal Infections , Streptococcus agalactiae , Humans , Nucleic Acid Amplification Techniques/methods , Streptococcus agalactiae/genetics , Streptococcus agalactiae/isolation & purification , Infant, Newborn , Neonatal Sepsis/diagnosis , Neonatal Sepsis/microbiology , Neonatal Sepsis/blood , Streptococcal Infections/diagnosis , Streptococcal Infections/blood , Streptococcal Infections/microbiology , Molecular Diagnostic Techniques/methods , Sensitivity and Specificity , DNA, Bacterial/genetics , DNA, Bacterial/blood , Bacterial Proteins/geneticsABSTRACT
PURPOSE: The incidence of invasive Streptococcus dysgalactiae subsp. equisimilis (iSDSE) infections is increasing in developed countries, but studies on the risk factors for death in iSDSE infections are scant. Here, we aimed to clarify risk factors and predictors of mortality in adults with iSDSE infections. METHODS: A multicentre observational study of adults with iSDSE infections was conducted to investigate the effects of host factors, disease severity, biomarkers, and antibiotic regimens, and bacterial factors on 28-day mortality. RESULTS: The overall mortality rate of 588 patients was 10.4%, with a significant increase in those aged ≥ 60 years. Most of the patients (97.4%) had underlying diseases. The mortality rate (70.4%) of patients with severe disease was significantly higher than that of patients with mild-to-moderate disease (4.3%; p < 0.001). The risk factors for death identified using multivariable analysis were age ≥ 60 years (hazard ratio [HR], 3.4; 95% confidence interval [CI], 1.0-11.3, p = 0.042); severe disease (HR, 15.0; 95% CI 7.7-29.2, p < 0.001); bacteraemia without primary focus (HR, 20.5; 95% CI 2.8-152.3, p = 0.003); serum creatinine ≥ 2.0 mg/dL (HR, 2.2; 95% CI 1.2-4.0, p = 0.010); serum creatine kinase ≥ 300 IU/L (HR, 2.1; 95% CI 1.1-3.8, p = 0.019); and macrolide resistance (HR, 1.8; 95% CI 1.0-3.3, p = 0.048). Treatment regimens and emm types were not associated with poor outcomes. CONCLUSION: Evaluation of clinical manifestations and biomarkers on admission is important to predict invasive SDSE infection prognosis.
Subject(s)
Biomarkers , Streptococcal Infections , Streptococcus , Humans , Streptococcal Infections/mortality , Streptococcal Infections/microbiology , Streptococcal Infections/blood , Streptococcal Infections/drug therapy , Middle Aged , Female , Male , Aged , Biomarkers/blood , Streptococcus/isolation & purification , Risk Factors , Adult , Anti-Bacterial Agents/therapeutic use , Aged, 80 and over , Severity of Illness Index , Young AdultABSTRACT
Objective: The aim of this study as to unveil changes in serum inflammatory factors in pregnant women with genital tract group B Streptococcus (GBS) infection and their predictive value for premature rupture of membranes (PROM) complicated by chorioamnionitis (CS) and adverse pregnancy outcomes. Methods: The value of serum inflammatory factor levels in predicting PROM complicating CS and adverse pregnancy outcomes in GBS-infected pregnant women was evaluated by ELISA. Results: Serum IL-6, TNF-α, PCT and hs-CRP levels were higher in pregnant women with GBS infection. The combined diagnosis of these factors had excellent diagnostic value in PROM complicating CS and adverse pregnancy outcomes. Conclusion: Joint prediction of IL-6, TNF-α, PCT and hs-CRP has the best predictive value for PROM complicating CS and adverse pregnancy outcomes.
[Box: see text].
Subject(s)
Chorioamnionitis , Fetal Membranes, Premature Rupture , Streptococcal Infections , Streptococcus agalactiae , Humans , Female , Pregnancy , Chorioamnionitis/blood , Chorioamnionitis/microbiology , Chorioamnionitis/diagnosis , Fetal Membranes, Premature Rupture/blood , Fetal Membranes, Premature Rupture/microbiology , Streptococcal Infections/blood , Streptococcal Infections/diagnosis , Streptococcal Infections/complications , Adult , C-Reactive Protein/metabolism , C-Reactive Protein/analysis , Tumor Necrosis Factor-alpha/blood , Interleukin-6/blood , Biomarkers/blood , Pregnancy Complications, Infectious/blood , Pregnancy Complications, Infectious/diagnosis , Pregnancy Complications, Infectious/microbiology , Procalcitonin/blood , Pregnancy Outcome , Predictive Value of TestsABSTRACT
BACKGROUND: Group B streptococcus is a major cause of neonatal disease. Natural history studies have linked maternally transferred anti-group B streptococcus capsular polysaccharide antibodies with protection against infant group B streptococcus disease. Previous studies of capsular polysaccharide antibody concentration in European populations have used maternal (not infant) sera and a non-standardised assay. This study aimed to evaluate anti-capsular polysaccharide IgG concentrations associated with protection against invasive group B streptococcus disease in Finnish infants. METHODS: In this retrospective case-control study, we used cord sera from the Finnish DIPP study repository, which was obtained between Jan 1, 1995, and Dec 31, 2017. We included infants aged 6 months or younger with group B streptococcus infection (cases) and healthy infants (controls). We enrolled infants with invasive neonatal group B streptococcus (55 cases) and matched controls (229 controls) aged 6 months or younger after identification from Finnish health registers. We measured anti-capsular polysaccharide IgG (serotypes Ia-V) concentration using a standardised immunoassay and we estimated its relationship to disease risk using a Bayesian model. We used the derived risk-concentration curve to predict potential efficacy of six-valent group B streptococcus capsular polysaccharide vaccine (GBS6) based on previously reported immunogenicity data. FINDINGS: Most (32 [58%] of 55 cases) group B streptococcus cases were due to serotype III and anti-serotype III streptococcus capsular IgG concentrations were higher in serotype III-matched controls than in cases (p<0·001). 0·120-0·266 µg/mL serotype III-specific IgG was estimated to confer 75-90% risk reduction against serotype III disease. A universal risk-concentration curve, aggregating results across all six serotypes, yielded similar results. Application of this curve to GBS6 immunogenicity data predicted maternal immunisation to be more than 80% efficacious for prevention of infant group B streptococcus disease. INTERPRETATION: Higher neonatal anti-capsular polysaccharide serum IgG concentration at birth correlated with reduced risk of infant group B streptococcus disease in Finland. Based on these results, a maternal group B streptococcus capsular conjugate vaccine currently in development is predicted to be efficacious. FUNDING: Pfizer.
Subject(s)
Antibodies, Bacterial , Immunoglobulin G , Streptococcal Infections , Streptococcus agalactiae , Humans , Finland/epidemiology , Retrospective Studies , Streptococcus agalactiae/immunology , Streptococcal Infections/immunology , Streptococcal Infections/prevention & control , Streptococcal Infections/blood , Streptococcal Infections/epidemiology , Case-Control Studies , Immunoglobulin G/blood , Immunoglobulin G/immunology , Female , Infant, Newborn , Antibodies, Bacterial/blood , Antibodies, Bacterial/immunology , Male , Infant , Streptococcal Vaccines/immunology , Streptococcal Vaccines/administration & dosage , Bacterial Capsules/immunologyABSTRACT
New therapeutic strategies to reduce sepsis-related mortality are urgently needed, as sepsis accounts for one in five deaths worldwide. Since hematopoietic stem and progenitor cells (HSPCs) are responsible for producing blood and immune cells, including in response to immunological stress, we explored their potential for treating sepsis. In a mouse model of Group A Streptococcus (GAS)-induced sepsis, severe immunological stress was associated with significant depletion of bone marrow HSPCs and mortality within approximately 5-7 days. We hypothesized that the inflammatory environment of GAS infection drives rapid HSPC differentiation and depletion that can be rescued by infusion of donor HSPCs. Indeed, infusion of 10,000 naïve HSPCs into GAS-infected mice resulted in rapid myelopoiesis and a 50-60% increase in overall survival. Surprisingly, mice receiving donor HSPCs displayed a similar pathogen load compared to untreated mice. Flow cytometric analysis revealed a significantly increased number of myeloid-derived suppressor cells in HSPC-infused mice, which correlated with reduced inflammatory cytokine levels and restored HSPC levels. These findings suggest that HSPCs play an essential immunomodulatory role that may translate into new therapeutic strategies for sepsis.
Subject(s)
Cell Differentiation/immunology , Hematopoietic Stem Cells/immunology , Immunomodulation , Sepsis/immunology , Stem Cells/immunology , Streptococcal Infections/blood , Animals , Cytokines/immunology , Female , Hematopoietic Stem Cell Transplantation/methods , Male , Mice , Mice, Inbred C57BL , Sepsis/therapy , Stem Cell Transplantation/methods , Streptococcal Infections/immunology , Streptococcus/immunology , Streptococcus/pathogenicityABSTRACT
BACKGROUND: Streptococcus agalactiae or Group B Streptococcus (GBS) is an encapsulated gram-positive bacterial pathobiont that commonly colonizes the lower gastrointestinal tract and reproductive tract of human hosts. This bacterium can infect the gravid reproductive tract and cause invasive infections of pregnant patients and neonates. Upon colonizing the reproductive tract, the bacterial cell is presented with numerous nutritional challenges imposed by the host. One strategy employed by the host innate immune system is intoxication of bacterial invaders with certain transition metals such as zinc. METHODOLOGY: Previous work has demonstrated that GBS must employ elegant strategies to circumnavigate zinc stress in order to survive in the vertebrate host. We assessed 30 strains of GBS from diverse isolation sources, capsular serotypes, and sequence types for susceptibility or resistance to zinc intoxication. RESULTS: Invasive strains, such as those isolated from early onset disease manifestations of GBS infection were significantly less susceptible to zinc toxicity than colonizing strains isolated from rectovaginal swabs of pregnant patients. Additionally, capsular type III (cpsIII) strains and the ST-17 and ST-19 strains exhibited the greatest resilience to zinc stress, whereas ST-1 and ST-12 strains as well as those possessing capsular type Ib (cpsIb) were more sensitive to zinc intoxication. Thus, this study demonstrates that the transition metal zinc possesses antimicrobial properties against a wide range of GBS strains, with isolation source, capsular serotype, and sequence type contributing to susceptibility or resistance to zinc stress.
Subject(s)
Anti-Bacterial Agents/pharmacology , Chlorides/pharmacokinetics , Serogroup , Streptococcus agalactiae/drug effects , Streptococcus agalactiae/genetics , Zinc Compounds/pharmacokinetics , Anti-Bacterial Agents/metabolism , Bacterial Capsules/classification , Bacterial Capsules/drug effects , Chlorides/metabolism , Female , Humans , Infant, Newborn , Microbial Sensitivity Tests , Pregnancy , Serotyping , Streptococcal Infections/blood , Streptococcal Infections/drug therapy , Streptococcal Infections/microbiology , Streptococcus agalactiae/classification , Streptococcus agalactiae/growth & development , Vagina/drug effects , Vagina/microbiology , Zinc Compounds/metabolismABSTRACT
<b>Background and Objective:</b> In recent years, respiratory tract viral infections have caused many pandemics that impact the whole world. To investigate the seropositivity of <i>Toxoplasma gondii</i>, rubella, CMV, HSV-1 and group A <i>Streptococcus</i> in recovered COVID-19 patients and correlate these findings with vitamin D levels. <b>Materials and Methods:</b> A total of 417 COVID-19 patients with diarrhoea were enrolled in this study. Vitamin D and seroprevalence for <i>Toxoplasma gondii</i>, rubella, CMV, HSV-1 and group A <i>Streptococcus</i> were evaluated and correlated. <b>Results:</b> It was found that recent infection in COVID-19 patients with HSV-1, rubella, <i>Toxoplasma</i> and CMV, respectively. IgG was detected indicating the development of adaptive immunity with all microbes. <b>Conclusion:</b> Current study detected a correlation between vitamin D levels and HSV-1 and no correlation between this infection and vitamin D deficiency with the other microbes.
Subject(s)
COVID-19 Serological Testing , COVID-19/diagnosis , Calcifediol/blood , Herpes Simplex/diagnosis , Herpesvirus 1, Human/immunology , Immunoglobulin G/blood , Vitamin D Deficiency/diagnosis , Adaptive Immunity , Adult , Biomarkers/blood , COVID-19/blood , COVID-19/epidemiology , COVID-19/immunology , Cytomegalovirus/immunology , Cytomegalovirus Infections/blood , Cytomegalovirus Infections/diagnosis , Cytomegalovirus Infections/epidemiology , Cytomegalovirus Infections/immunology , Female , Herpes Simplex/blood , Herpes Simplex/epidemiology , Herpes Simplex/immunology , Humans , Male , Middle Aged , Predictive Value of Tests , Prevalence , Rubella/blood , Rubella/diagnosis , Rubella/epidemiology , Rubella/immunology , Rubella virus/immunology , Saudi Arabia/epidemiology , Seroepidemiologic Studies , Streptococcal Infections/blood , Streptococcal Infections/diagnosis , Streptococcal Infections/epidemiology , Streptococcal Infections/immunology , Streptococcus/immunology , Toxoplasma/immunology , Toxoplasmosis/blood , Toxoplasmosis/diagnosis , Toxoplasmosis/epidemiology , Toxoplasmosis/immunology , Vitamin D Deficiency/blood , Vitamin D Deficiency/epidemiologyABSTRACT
BACKGROUND: Purpura and glomerulonephritis are typical presentations in IgA vasculitis. Infective endocarditis mimicking IgA vasculitis by presenting with glomerulonephritis and purpura is rarely reported. METHODS: We searched for cases with infective endocarditis-associated purpura and glomerulonephritis in a tertiary hospital in China and retrospectively reviewed their clinicopathological features. Differential diagnosis and treatment in patients with infective endocarditis-associated purpura and glomerulonephritis were discussed. RESULTS: A total of 20 cases with infective endocarditis-associated purpura and glomerulonephritis were identified among 548 cases with infective endocarditis in our center during an 8-year period: 7 of the 20 cases (35%) were initially misdiagnosed as IgA vasculitis and 10 cases (50%) presented with left-sided endocarditis caused by Streptococcus viridans. Fever (100%, 20 out of 20), prior valvular deformities (80%, 16 out of 20), cardiac murmur (95%, 19 out of 20), splenomegaly (84%, 16 out of 19), embolism (55%, 11 out of 20), and hypocomplementemia (76%, 13 out of 17) were present in most patients. Crescents and mesangial hypercellularity with or without endothelial hypercellularity were the primary findings on light microscopy, with C3-dominant deposition on immunofluorescence. But IgA-dominant staining was also observed (40%, 2 out of 5). In patients with rapidly progressive glomerulonephritis, patients with complete recovery of renal function had shorter disease duration and higher ratio (67% vs 20%) of immunosuppressive therapy compared with patients with partial recovery. CONCLUSIONS: Infective endocarditis-associated glomerulonephritis and purpura can closely mimic IgA vasculitis. Differential diagnosis is challenging, particularly when typical presentations of infective endocarditis are absent. In adults with presentations like IgA vasculitis, infective endocarditis should be evaluated through comprehensive clinical and pathological investigations. Immunosuppressive therapy can be considered in patients with severe glomerulonephritis who do not improve after proper anti-infective therapy.
Subject(s)
Endocarditis/diagnosis , Glomerulonephritis/physiopathology , IgA Vasculitis/diagnosis , Purpura/physiopathology , Streptococcal Infections/diagnosis , Adult , Antibodies, Antineutrophil Cytoplasmic/blood , Antibodies, Antinuclear/blood , Antibodies, Antiphospholipid/blood , Autoantibodies/blood , Complement System Proteins/metabolism , Diagnosis, Differential , Endocarditis/blood , Endocarditis/complications , Endocarditis/physiopathology , Female , Glomerulonephritis/blood , Glomerulonephritis/etiology , Glomerulonephritis/pathology , Humans , Immunosuppressive Agents/therapeutic use , Male , Middle Aged , Purpura/blood , Purpura/etiology , Rheumatoid Factor/blood , Streptococcal Infections/blood , Streptococcal Infections/complications , Streptococcal Infections/physiopathology , Thrombocytopenia/blood , Viridans Streptococci , Young AdultABSTRACT
BACKGROUND: Streptococcus suis (Ss) is a Gram-positive and anaerobic zoonotic pathogen that is susceptible to all populations and can cause meningitis, septicemia, endocarditis and arthritis in humans. METHODS: In this study, patients with meningitis who were admitted to our hospital with negative blood and cerebrospinal fluid culture were divided into a next-generation sequencing group and a control group. In the next-generation sequencing group, we used the next-generation sequencing method to detect pathogenic bacteria in the patients' cerebrospinal fluid. In the control group, we used blood and cerebrospinal fluid bacterial culture method to detect pathogenic bacteria in the patients' cerebrospinal fluid. The detection rates of pathogenic bacteria in the cerebrospinal fluid of the two groups were compared and analyzed. RESULTS: A total of 18 patients were included in this study, including 8 patients in the next-generation sequencing group and 10 patients in the control group. The mean age (P = 0.613) and mean disease duration (P = 0.294) were similar in both groups. Patients in the next-generation sequencing group had a leukocyte count of 13.13 ± 4.79 × 109, a neutrophil percentage of 83.39 ± 10.36%, and a C-reactive protein level of 134.95 ± 107.69 mg/L. Patients in the control group had a temperature of 38.32 ± 1.07, a leukocyte count of 8.00 ± 2.99 × 109, and a neutrophil percentage of 74.61 ± 8.89%, and C-reactive protein level was 4.75 ± 6.8 mg/L. The statistical results showed that the leukocytes (P = 0.013) and C-reactive protein levels (P = 0.001) were significantly higher in the patients of the next-generation sequencing group than in the control group. No statistically significant differences were seen in body temperature and neutrophil percentage between the two groups (P > 0.05). The incidence of intracranial pressure and meningeal irritation signs were similar in the two groups (P > 0.05). The detection rate of Streptococcus suis in the cerebrospinal fluid of patients in the next-generation sequencing group was 100%, and the detection rate of Streptococcus suis in the cerebrospinal fluid of the control group was 0%. CONCLUSION: The detection rate of Streptococcus suis infection in cerebrospinal fluid by next-generation sequencing was significantly higher than that by blood and cerebrospinal fluid bacterial culture. Therefore, the diagnosis of porcine streptococcal meningitis by next-generation sequencing method is worthy of clinical promotion and application.
Subject(s)
Blood/microbiology , Cerebrospinal Fluid/microbiology , Culture Techniques/methods , High-Throughput Nucleotide Sequencing/methods , Meningitis, Bacterial/diagnosis , Streptococcal Infections/diagnosis , Streptococcus suis/isolation & purification , Animals , Case-Control Studies , Cerebrospinal Fluid/metabolism , Female , Follow-Up Studies , Humans , Male , Meningitis, Bacterial/blood , Meningitis, Bacterial/cerebrospinal fluid , Meningitis, Bacterial/microbiology , Middle Aged , Prognosis , Streptococcal Infections/blood , Streptococcal Infections/cerebrospinal fluid , Streptococcal Infections/microbiology , Streptococcus suis/genetics , SwineABSTRACT
Streptococcus agalactiae is one of the most important pathogens infecting tilapia worldwide and causes meningoencephalitis, septicemia and high mortalities with considerable losses. Various types of vaccines have been developed against S. agalactiae infection, such as inactivated vaccines, live attenuated vaccines and subunit vaccines. Bacterial ghosts (BGs) are nonliving, empty cell envelopes and have been reported as novel vaccine candidates. Therefore, the main aims of this study were to develop an S. agalactiae ghost vaccine (SAGV) and to evaluate the immune response and protective effect of SAGV against S. agalactiae with two novel adjuvants, Montanide™ ISA 763B VG and Montanide™ GEL02. Nile tilapia, mean weight 50 g, were divided into four groups as follows; 1) fish injected with PBS as control, 2) fish injected with the SAGV alone; 3) fish injected with the SAGV+Montanide™ ISA 763B VG; and 4) fish injected with SAGV+Montanide™ GEL02. Following vaccination, innate immunity parameters including serum lysozyme, myeloperoxidase, catalase, and bactericidal activity were all significantly enhanced. Moreover, specific serum IgM antibodies were induced and reached their highest level 2-8 weeks post vaccination. Importantly, the relative percent survival of tilapia vaccinated against the SAGV formulated with both adjuvants was 80-93%. Furthermore, the transcription of immune-related genes (IgM, TCRß, IL-1ß, IL-8 and TNFα) were up-regulated in tilapia after vaccination, indicating that both cellular and humoral immune responses were induced by these adjuvanted vaccines. In summary, Montanide™ ISA 763B VG and Montanide™ GEL02 can enhance immunoprotection induced by the SAGV vaccine against streptococcosis, demonstrating that both have value as potential adjuvants of fish vaccines.
Subject(s)
Adjuvants, Immunologic/administration & dosage , Cichlids/immunology , Fish Diseases/prevention & control , Mannitol/analogs & derivatives , Mannitol/administration & dosage , Streptococcal Infections/prevention & control , Streptococcal Vaccines/administration & dosage , Streptococcus agalactiae/immunology , Animals , Antibodies, Bacterial/blood , Catalase/blood , Cichlids/blood , Fish Diseases/blood , Fish Diseases/immunology , Fish Proteins/blood , Liver/immunology , Muramidase/blood , Peroxidase/blood , Spleen/immunology , Streptococcal Infections/blood , Streptococcal Infections/immunologyABSTRACT
BACKGROUND: Group A Streptococcus can cause serious and sometimes life-threatening disease in children. The past few years have witnessed a rise in invasive group A Streptococcus infection (iGASi) for unclear reasons. This study attempted to describe the epidemiology, the clinical and demographic characteristics and the outcomes associated with iGASi in hospitalized children in central Israel. METHODS: We retrospectively analyzed the medical records of children <18 years old discharged with a diagnosis of iGASi between January 2012 and December 2019. Clinical, laboratory and microbiologic data, and immunization status were retrieved. The patients were divided into severe and nonsevere groups based on their clinical presentation. The emm type was determined at the national reference center. RESULTS: A total of 167 patients with 206 positive cultures for group A Streptococcus were identified. Hospitalizations for iGASi increased from 701 to 958 per 100,000 admissions between 2012-2015 and 2016-2019, respectively, representing an increase of 37%. The majority of the isolates were from the otolaryngologic system followed by blood, deep soft tissue and respiratory sites. Uncomplicated mastoiditis was the most common diagnosis, followed by bacteremia. Pneumonia was the main diagnosis in the severe group (39.4%). CONCLUSIONS: The admissions because of iGASi in children <18 years old increased during the last 8 years. Surveillance systems and prospective studies should be conducted to expend our understanding of the epidemiology of iGASi in children, better assess the pathogenesis and specific risk factors and monitor changes in emm-type distribution.
Subject(s)
Hospitalization/statistics & numerical data , Streptococcal Infections/blood , Streptococcal Infections/epidemiology , Adolescent , Age Distribution , Anti-Bacterial Agents/therapeutic use , Bacteremia/epidemiology , Child , Child, Preschool , Female , Humans , Incidence , Infant , Israel/epidemiology , Male , Mastoiditis/epidemiology , Mastoiditis/microbiology , Pneumonia, Bacterial/epidemiology , Prospective Studies , Retrospective Studies , Risk Factors , Streptococcal Infections/complications , Streptococcal Infections/drug therapy , Streptococcus pyogenes/pathogenicity , Tertiary Care Centers/statistics & numerical dataABSTRACT
BACKGROUND: Prevention strategies can reduce the incidence of early-onset group B Streptococcus (GBS) neonatal sepsis (EOGBS). Rates of GBS colonization and infection vary among regions within China. China has not adopted a unified prevention strategy. METHODS: To assess strategies to reduce EOGBS in China, models were developed to quantify residual EOGBS rates with intrapartum antibiotic prophylaxis in infants ≥ 35 weeks' gestation in risk factor-based and antepartum screening-based strategies. Maternal GBS colonization rates and EOGBS incidence in 3 regions of China (A: Xiamen of Fujian province, B: Shanghai and C: Liuzhou of Guangxi province) were estimated from published data. RESULTS: Estimates for GBS colonization and attack rates were 21.6%, 11.7% and 6.1% and 1.79, 1.79 and 0.58 per 1000 live births for regions A, B and C, respectively. Modeling predicted that strategies including screening cultures beginning at 36 weeks' gestation and intrapartum antibiotic prophylaxis in 90% of eligible parturients could reduce EOGBS incidence to 0.44, 0.50 and 0.16 per 1000 live births in these regions. In region C, the expected EOGBS rate could be reduced to 0.28 per 1000 using a risk factor-based strategy. CONCLUSIONS: Different strategies for preventing EOGBS may be needed in different regions of mainland China. Screening strategies may be most appropriate in regions with higher attack rates, even with moderate levels of maternal GBS colonization. In areas with low attack rates, risk factor strategies that reduce morbidity by at least one-third may suffice.
Subject(s)
Infectious Disease Transmission, Vertical/prevention & control , Neonatal Sepsis/prevention & control , Streptococcal Infections/prevention & control , Streptococcus agalactiae/pathogenicity , Antibiotic Prophylaxis , China/epidemiology , Female , Geography , Gestational Age , Humans , Incidence , Infant, Newborn , Neonatal Sepsis/epidemiology , Pregnancy , Pregnancy Complications, Infectious/microbiology , Pregnancy Complications, Infectious/prevention & control , Risk Factors , Streptococcal Infections/blood , Streptococcal Infections/epidemiologyABSTRACT
CASE PRESENTATION: A 70-year-old man presented to the ED with sudden onset of left thigh pain followed by transient chest discomfort. His history included cerebrovascular disease, hypertension, and cocaine and methamphetamine use. Physical examination revealed an uncomfortable male subject with a temperature of 37 °C, heart rate of 129 beats/min, BP of 130/65 mm Hg, and 98% oxygen saturation on room air. There was point tenderness in the left lateral thigh without erythema, swelling, or overlying skin changes. His cardiac examination revealed an irregular tachycardia at 129 beats/min and normal first and second heart sounds without murmurs, gallops, or rubs. The remainder of the examination was unremarkable.
Subject(s)
Pericardial Effusion , Pericarditis , Streptococcal Infections , Streptococcus pyogenes/isolation & purification , Aged , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/classification , Autopsy , Chest Pain/diagnosis , Chest Pain/etiology , Clinical Deterioration , Diagnosis, Differential , Echocardiography/methods , Electrocardiography/methods , Fatal Outcome , Humans , Male , Pericardial Effusion/diagnosis , Pericardial Effusion/etiology , Pericardial Effusion/physiopathology , Pericarditis/diagnosis , Pericarditis/microbiology , Pericarditis/physiopathology , Pericarditis/therapy , Streptococcal Infections/blood , Streptococcal Infections/physiopathology , Streptococcal Infections/therapy , Suppuration , Thigh/pathology , Thigh/physiopathology , Tomography, X-Ray Computed/methodsSubject(s)
Aeromonas salmonicida/physiology , Bacteriophage lambda/physiology , Biological Evolution , Escherichia coli/genetics , Escherichia coli/virology , Fish Diseases/microbiology , Streptococcal Infections/microbiology , Streptococcus/metabolism , Aeromonas salmonicida/genetics , Animals , Bacteriophage lambda/genetics , Cell Membrane/chemistry , Cell Membrane/genetics , Editorial Policies , Escherichia coli/immunology , Streptococcal Infections/blood , Streptococcus/chemistry , Streptococcus/growth & developmentABSTRACT
Serum amyloid A (SAA) and Haptoglobin (Hp) are acute phase proteins, produced during inflammation, such as placentitis. In horses, SAA and SAA1 are protein coding genes. Objectives were to analyze SAA and Hp concentrations and relative abundance of SAA, SAA1 and Hp mRNA transcript in maternal and fetal tissues after experimental induction of placentitis or mares of a control group. Serum Amyloid A family proteins were in marked abundance in the stroma of the endometrium and chorioallantois associated with inflammatory cells. Maternal plasma SAA concentrations were greater (P = 0.01) in mares with experimentally induced placentitis compared to those of the control group. Maternal Hp from the groups were not different, but fetal Hp concentrations of mares with experimentally induced placentitis were greater (P = 0.02). Maternal plasma SAA and Hp concentrations were greater than fetal plasma concentrations in mares with experimentally induced placentitis (P < 0.05). Relative abundance of SAA mRNA transcript was greater in the maternal, fetal liver and chorioallantois of mares with experimentally induced placentitis (P < 0.05) compared to those in the control group. Interestingly, relative abundance of SAA1 mRNA transcript was greater in the chorioallantois of mares with experimentally induced placentitis (P < 0.05). The SAA and Hp concentrations, therefore, were greater in mares with induced placentitis. Furthermore, relative abundance of SAA1 mRNA transcript is specifically greater in the chorioallantois of mares with placentitis, which warrants further studies to elucidate the immunological response of SAA1 in the chorioallantois of mares with placentitis.
Subject(s)
Haptoglobins/metabolism , Horse Diseases/blood , Placenta Diseases/veterinary , Serum Amyloid A Protein/metabolism , Streptococcal Infections/veterinary , Animals , Female , Fetus , Horse Diseases/chemically induced , Horse Diseases/microbiology , Horses , Placenta Diseases/blood , Placenta Diseases/microbiology , Pregnancy , Streptococcal Infections/blood , Streptococcal Infections/metabolism , Streptococcus equiABSTRACT
Streptococcus pneumoniae, S. pyogenes (Group A Streptococcus; GAS) and S. agalactiae (Group B Streptococcus; GBS) are major aetiological agents of diseases in humans. The cellular membrane, a crucial site in host-pathogen interactions, is poorly characterized in streptococci. Moreover, little is known about whether or how environmental conditions influence their lipid compositions. Using normal phase liquid chromatography coupled with electrospray ionization MS, we characterized the phospholipids and glycolipids of S. pneumoniae, GAS and GBS in routine undefined laboratory medium, streptococcal defined medium and, in order to mimic the host environment, defined medium supplemented with human serum. In human serum-supplemented medium, all three streptococcal species synthesize phosphatidylcholine (PC), a zwitterionic phospholipid commonly found in eukaryotes but relatively rare in bacteria. We previously reported that S. pneumoniae utilizes the glycerophosphocholine (GPC) biosynthetic pathway to synthesize PC. Through substrate tracing experiments, we confirm that GAS and GBS scavenge lysoPC, a major metabolite in human serum, thereby using an abbreviated GPC pathway for PC biosynthesis. Furthermore, we found that plasmanyl-PC is uniquely present in the GBS membrane during growth with human serum, suggesting GBS possesses unusual membrane biochemical or biophysical properties. In summary, we report cellular lipid remodelling by the major pathogenic streptococci in response to metabolites present in human serum.
Subject(s)
Phospholipids/metabolism , Serum/metabolism , Streptococcal Infections/microbiology , Streptococcus agalactiae/metabolism , Streptococcus pneumoniae/metabolism , Streptococcus pyogenes/metabolism , Cell Membrane/chemistry , Cell Membrane/genetics , Culture Media/metabolism , Humans , Phospholipids/chemistry , Streptococcal Infections/blood , Streptococcus agalactiae/chemistry , Streptococcus agalactiae/growth & development , Streptococcus pneumoniae/chemistry , Streptococcus pneumoniae/growth & development , Streptococcus pyogenes/chemistry , Streptococcus pyogenes/growth & developmentABSTRACT
Introduction. Group A streptococci can trigger autoimmune responses that lead to acute rheumatic fever (ARF) and rheumatic heart disease (RHD).Gap Statement. Some autoantibodies generated in ARF/RHD target antigens in the S2 subfragment region of cardiac myosin. However, little is known about the kinetics of these antibodies during the disease process.Aim. To determine the antibody responses over time in patients and healthy controls against host tissue proteins - cardiac myosin and peptides from its S2 subfragment, tropomyosin, laminin and keratin.Methodology. We used enzyme-linked immunosorbent assays (ELISA) to determine antibody responses in: (1) healthy controls; (2) patients with streptococcal pharyngitis; (3) patients with ARF with carditis and (4) patients with RHD on penicillin prophylaxis.Results. We observed significantly higher antibody responses against extracellular proteins - laminin and keratin in pharyngitis group, patients with ARF and patients with RHD when compared to healthy controls. The antibody responses against intracellular proteins - cardiac myosin and tropomyosin were elevated only in the group of patients with ARF with active carditis. While the reactivity to S2 peptides S2-1-3, 8-11, 14, 16-18, 21-22 and 32 was higher in patients with ARF, the reactivity in the RHD group was high only against S2-1, 9, 11, 12 when compared to healthy controls. The reactivity against S2 peptides reduced as the disease condition stabilized in the ARF group whereas the reactivity remained unaltered in the RHD group. By contrast antibodies against laminin and keratin persisted in patients with RHD.Conclusion. Our findings of antibody responses against host proteins support the multistep hypothesis in the development of rheumatic carditis. The differential kinetics of serum antibody responses against S2 peptides may have potential use as markers of ongoing cardiac damage that can be used to monitor patients with ARF/RHD.
Subject(s)
Autoantibodies/immunology , Autoantigens/immunology , Rheumatic Fever/immunology , Rheumatic Heart Disease/immunology , Autoantibodies/blood , Autoantigens/chemistry , Cardiac Myosins/chemistry , Cardiac Myosins/immunology , Humans , Keratins/immunology , Laminin/immunology , Longitudinal Studies , Peptides/chemistry , Peptides/immunology , Rheumatic Fever/blood , Rheumatic Heart Disease/blood , Streptococcal Infections/blood , Streptococcal Infections/immunology , Streptococcus pyogenes/immunology , Tropomyosin/immunologyABSTRACT
Streptococcus agalactiae or group B streptococcus (GBS) is a pathogen that causes severe neonatal infections, resulting in sepsis, pneumonia, and meningitis. Neonatal GBS meningitis has a poor neurological prognosis and a high mortality rate. GBS disease is classified as early- and late-onset if the onset age is 0-6 and 7-89 days after birth, respectively. There is currently no effective preventive strategy against late-onset GBS (LOGBS) disease. Here, we report a case of female infant with LOGBS meningitis who recovered from the septic shock by two exchange transfusions (ExTs) but still experienced severe neurological sequela. She was born at a gestational age of 39 weeks via caesarian section due to oligohydramnios and had fever 11 days after birth. GBS was detected in her cerebrospinal fluid (CSF) and blood but not in the vaginal or breast-milk cultures of the mother. The patient was treated with intravenous antibiotic administration; however, she suddenly developed pulseless ventricular tachycardia and asystole the next day. Her heart rate was normalized via cardiopulmonary resuscitation. We also performed two ExTs, and she recovered from the septic shock. Cytokine-profile analysis revealed that the serum and CSF levels of various pro-inflammatory and anti-inflammatory cytokines were elevated before the ExTs, after which the serum levels of several of these cytokines decreased. Two ExTs were effective in saving the life of the patient but did not improve the neurological prognosis. Given that neonatal GBS meningitis has high fatality and sequela rates; thus, it is necessary to establish a preventive strategy.
Subject(s)
Cytokines/blood , Cytokines/cerebrospinal fluid , Exchange Transfusion, Whole Blood , Meningitis, Bacterial/blood , Meningitis, Bacterial/microbiology , Streptococcal Infections/blood , Streptococcal Infections/microbiology , Streptococcus agalactiae/physiology , Adult , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Meningitis, Bacterial/cerebrospinal fluid , Streptococcal Infections/cerebrospinal fluidABSTRACT
The arginine deiminase (ADI) pathway has been found in many kinds of bacteria and functions to supplement energy production and provide protection against acid stress. The Streptococcus pyogenes ADI pathway is upregulated upon exposure to various environmental stresses, including glucose starvation. However, there are several unclear points about the advantages to the organism for upregulating arginine catabolism. We show that the ADI pathway contributes to bacterial viability and pathogenesis under low-glucose conditions. S. pyogenes changes global gene expression, including upregulation of virulence genes, by catabolizing arginine. In a murine model of epicutaneous infection, S. pyogenes uses the ADI pathway to augment its pathogenicity by increasing the expression of virulence genes, including those encoding the exotoxins. We also find that arginine from stratum-corneum-derived filaggrin is a key substrate for the ADI pathway. In summary, arginine is a nutrient source that promotes the pathogenicity of S. pyogenes on the skin.
Subject(s)
Arginine/metabolism , Skin/microbiology , Streptococcus pyogenes/pathogenicity , Animals , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Filaggrin Proteins , Gene Expression Regulation, Bacterial , HaCaT Cells , Humans , Hydrolases/metabolism , Male , Mice, Inbred C57BL , Mice, Knockout , Microbial Viability , Phosphorylation , Skin/pathology , Streptococcal Infections/blood , Streptococcal Infections/microbiology , Streptococcal Infections/pathology , Streptococcus pyogenes/genetics , Transcriptome/genetics , Up-Regulation , VirulenceABSTRACT
BACKGROUND: Chorioamnionitis may cause serious perinatal and neonatal adverse outcomes, and group B streptococcus (GBS) is one of the most common bacteria isolated from human chorioamnionitis. The present study analyzed the impact of GBS infection and histological chorioamnionitis (HCA) on pregnancy outcomes and the diagnostic value of various biomarkers. METHODS: Pregnant women were grouped according to GBS infection and HCA detection. Perinatal and neonatal adverse outcomes were recorded with a follow-up period of 6 weeks. The white blood cell count (WBC), neutrophil ratio, and C-reactive protein (CRP) level from peripheral blood and soluble intercellular adhesion molecule-1 (sICAM-1), interleukin 8 (IL-8), and tumor necrosis factor α (TNF-α) levels from cord blood were assessed. RESULTS: A total of 371 pregnant women were included. Pregnant women with GBS infection or HCA had a higher risk of pathological jaundice and premature rupture of membranes and higher levels of sICAM-1, IL-8, and TNF-α in umbilical cord blood. Univariate and multivariate regression analysis revealed that sICMA-1, IL-8, TNF-α, WBC, and CRP were significantly related to an increased HCA risk. For all included pregnant women, TNF-α had the largest receiver operating characteristic (ROC) area (area: 0.841; 95% CI: 0.778-0.904) of the biomarkers analyzed. TNF-α still had the largest area under the ROC curve (area: 0.898; 95% CI: 0.814-0.982) for non-GBS-infected pregnant women, who also exhibited a higher neutrophil ratio (area: 0.815; 95% CI: 0.645-0.985) and WBC (area: 0.849; 95% CI: 0.72-0.978), but all biomarkers had lower value in the diagnosis of HCA in GBS-infected pregnant women. CONCLUSION: GBS infection and HCA correlated with several perinatal and neonatal adverse outcomes. TNF-α in cord blood and WBCs in peripheral blood had diagnostic value for HCA in non-GBS-infected pregnant women but not GBS-infected pregnant women.